Association between serum soluble Toll-like receptor 2 and 4 and the risk of breast cancer.
In conclusion, sTLR2 and sTLR4 may be potential biomarkers of breast cancer susceptibility.
PMID: 33414918 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: El-Kharashy G, Gowily A, Okda T, Houssen M Tags: Mol Clin Oncol Source Type: research